» Articles » PMID: 15646426

Measuring Dyspepsia: a New Severity Index Validated in Bologna

Overview
Journal Dig Liver Dis
Publisher Elsevier
Specialty Gastroenterology
Date 2005 Jan 14
PMID 15646426
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Measurement of the severity of dyspepsia symptoms before and after treatment and determining what is a significant change is a major problem in designing dyspepsia treatment studies.

Objectives: To assess the reproducibility, validity and responsiveness to treatment of a dyspepsia questionnaire to be used in clinical and population-based studies.

Methods: Seventy-three dyspeptic patients (35 male, 38 female; mean age 52 years) and 75 healthy volunteers (32 male, 43 female; mean age 52 years) were included. Subjects were interviewed for the presence/absence and severity/frequency of 19 gastrointestinal symptoms. Severity was measured on a 5-point scale. Frequency was also recorded on a 5-point scale. A global symptom index (severity x frequency) was calculated for the eight most severe symptoms; a mean global symptom index (8-MGSI) was considered for the evaluation of the instrument. To evaluate intra-observer variation, one author interviewed subjects (T0) and then repeated the interview 1 week later (T1). For inter-observer variation, two authors interviewed patients. VALIDITY was measured by comparing 8-MGSI of the dyspepsia patients to those of healthy volunteers. Responsiveness was assessed by comparing mean global symptom index before and 1 month after appropriate therapy.

Results: Reproducibility: The mean 8-MGSI was 4.5 at T0 and 3.7 at T1 with a correlation coefficient of 0.62. As for inter-observer variation, the average 8-MGSI was 4.8 by the first author and 3.9 by the second with a correlation coefficient of 0.60.

Validity: The mean 8-MGSI was, respectively, 1.4 in healthy volunteers and 4.8 in dyspeptic patients (p = 0.001). Responsiveness: After treatment, a significant improvement in 8-MGSI was detected (p = 0.001).

Conclusions: This questionnaire is a reliable, valid and responsive instrument for measuring the presence, severity and frequency of dyspepsia.

Citing Articles

Patient-reported outcome measures in functional dyspepsia: a systematic review and COSMIN analysis.

Wang X, Fei Y, Li W, Liu H, Xiao H, Wu Y BMC Gastroenterol. 2023; 23(1):316.

PMID: 37726672 PMC: 10507973. DOI: 10.1186/s12876-023-02935-9.


Identifying the best regimen for primary eradication of Helicobacter pylori: analysis of 240 cases.

Chen Y, Liu Q, Hu F, Ma J Microbiologyopen. 2020; 9(11):e1120.

PMID: 33026166 PMC: 7658452. DOI: 10.1002/mbo3.1120.


Effects of anti-H. pylori triple therapy and a probiotic complex on intestinal microbiota in duodenal ulcer.

Wu L, Wang Z, Sun G, Peng L, Lu Z, Yan B Sci Rep. 2019; 9(1):12874.

PMID: 31492912 PMC: 6731296. DOI: 10.1038/s41598-019-49415-3.


Gut-directed hypnotherapy versus standard medical treatment for nausea in children with functional nausea or functional dyspepsia: protocol of a multicentre randomised trial.

Browne P, den Hollander B, Speksnijder E, van Wering H, Tjon A Ten W, George E BMJ Open. 2019; 9(4):e024903.

PMID: 30975672 PMC: 6500305. DOI: 10.1136/bmjopen-2018-024903.


Enzyme therapy for functional bowel disease-like post-prandial distress.

Graham D, Ketwaroo G, Money M, Opekun A J Dig Dis. 2018; 19(11):650-656.

PMID: 30101562 PMC: 6910206. DOI: 10.1111/1751-2980.12655.